Pharmacological Targeting of PI3K/Akt/mTOR and Wnt/GSK-3β Signaling in Oligodendrocyte Differentiation and Remyelination
Cells · 31.05.2026 · 15 (11) · 1012
DOI: 10.3390/cells15111012 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 31.05.2026. Verfasst von Mi Eun Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Research Lab & BK21-Four Educational Research Group for Age-Associated Disorder Control Technology, Department of Biological Science, Chos…. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Cell Differentiation, Oligodendroglia, Remyelination. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chosun University.
Abstract (Originalsprache)
Demyelinating diseases are characterized by loss of myelin and impaired neuronal function. Differentiation of oligodendrocyte progenitor cells (OPCs) and neural stem and progenitor cells is regulated by intracellular kinase signaling pathways. PI3K/Akt/mTOR and Wnt/GSK-3β signaling are involved in oligodendrocyte maturation and neurogenesis, and pharmacological modulation of these pathways affects myelin formation and neuronal differentiation. Small-molecule compounds targeting these pathways influence protein synthesis, lipid production, and β-catenin-dependent transcription. Activation of Akt and mTOR is associated with increased myelin-related protein expression, whereas inhibition of mTOR reduces oligodendrocyte differentiation. In contrast, inhibition of GSK-3β affects β-catenin stability and is associated with oligodendrocyte differentiation. These pathways also affect proliferation and differentiation of neural stem and progenitor cells. However, effects observed in experimental demyelination models have not been established as direct evidence of remyelination in patients. In addition, pharmacological agents act on multiple cell populations in the central nervous system (CNS), which complicates interpretation of their effects on specific cell types. This review examines pharmacological targeting of PI3K/Akt/mTOR and Wnt/GSK-3β signaling and describes intracellular mechanisms involved in oligodendrocyte and neuronal differentiation, with consideration of therapeutic application in demyelinating diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology Research Lab & BK21-Four Educational Research Group for Age-Associated Disorder Control Technology, Department of Biological Science, Chosun University, Gwangju 61452, Republic of Korea.
ORCID-Profile: Jun Sik Lee
Förderung
- Chosun University
Zitieren
APA
Kim, M. E., & Lee, J. S. (2026). Pharmacological Targeting of PI3K/Akt/mTOR and Wnt/GSK-3β Signaling in Oligodendrocyte Differentiation and Remyelination. Cells, 15(11), 1012. https://doi.org/10.3390/cells15111012
Vancouver
Kim ME, Lee JS. Pharmacological Targeting of PI3K/Akt/mTOR and Wnt/GSK-3β Signaling in Oligodendrocyte Differentiation and Remyelination. Cells. 2026;15(11):1012. doi:10.3390/cells15111012
BibTeX
@article{Kim2026,
author = {Kim, Mi Eun and Lee, Jun Sik},
title = {Pharmacological Targeting of PI3K/Akt/mTOR and Wnt/GSK-3β Signaling in Oligodendrocyte Differentiation and Remyelination},
journal = {Cells},
year = {2026},
volume = {15},
number = {11},
pages = {1012},
doi = {10.3390/cells15111012}
}
EUVIMED